• Fusion Pharmaceuticals Acquires IPN-1087 contractpharma
    March 03, 2021
    Fusion Pharmaceuticals Inc. has entered into an asset purchase agreement (APA) to acquire Ipsen's intellectual property and assets related to IPN-1087.
PharmaSources Customer Service